D
40
2
CSX
57
-4
DHR
32
-6
AAPL
40
-6
THC
60
-5
NWSA
62
-7
ED
45
3
CINF
53
3
ICE
59
-3
XEL
67
2
CTAS
53
-3
HCA
48
-2
MMM
35
-5
DIS
85
3
FAST
57
-3
JNPR
50
-6
AXP
67
-2
SE
60
-3
DD
53
-6
PG
50
2
D
40
2
CSX
57
-4
DHR
32
-6
AAPL
40
-6
THC
60
-5
NWSA
62
-7
ED
45
3
CINF
53
3
ICE
59
-3
XEL
67
2
CTAS
53
-3
HCA
48
-2
MMM
35
-5
DIS
85
3
FAST
57
-3
JNPR
50
-6
AXP
67
-2
SE
60
-3
DD
53
-6
PG
50
2
Financhill
Back

First Trust Dev Mkts Ex-US AlphaDEX® ETF Vs. Neurogene Industry Stock Comparison

Sell
34

FDT
First Trust Dev Mkts Ex-US AlphaDEX® ETF

Last Price:
55.16
Seasonality Move:
3.2%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
34
First Trust Dev Mkts Ex-US AlphaDEX® ETF (FDT) is a Sell

Is First Trust Dev Mkts Ex-US AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Dev Mkts Ex-US AlphaDEX® ETF [FDT] share price is $56.01. The Score for FDT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FDT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FDT Stock Price Chart

What is First Trust Dev Mkts Ex-US AlphaDEX® ETF's stock price today?

  • The First Trust Dev Mkts Ex-US AlphaDEX® ETF share price today is $56.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDT is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

FDT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 47.24 Sell
Chaikin Money Flow: 165266 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.72 - 56.9) Sell
Bollinger Bands (100): (54.86 - 57.48) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

FDT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.14 Sell
20-day SMA: 56.15 Sell
50-day SMA: 56.67 Sell
200-day SMA: 55.63 Buy
8-day EMA: 55.91 Buy
20-day EMA: 56.21 Sell
50-day EMA: 56.38 Sell
200-day EMA: 55.35 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

First Trust Dev Mkts Ex-US AlphaDEX® ETF Earnings Growth & FDT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

First Trust Dev Mkts Ex-US AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):